TriangleFOR PATIENTS · SOURCE READING
Targeted therapy
Source: Non-Small Cell Lung Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 16, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview / The following types of treatment are used:
Targeted therapy uses drugs or other substances to identify and attack specific cancer cells. Your doctor may suggest biomarker tests to help predict your response to certain targeted therapy drugs. Learn more about Biomarker Testing for Cancer Treatment.
Source links and citations
Targeted therapies used to treat non-small cell lung cancer include:
adagrasib
Source links and citations
afatinib
Source links and citations
alectinib
Source links and citations
amivantamab
Source links and citations
bevacizumab
Source links and citations
brigatinib
Source links and citations
capmatinib
Source links and citations
ceritinib
Source links and citations
cetuximab
Source links and citations
crizotinib
Source links and citations
dabrafenib
Source links and citations
dacomitinib
Source links and citations
entrectinib
Source links and citations
erlotinib
Source links and citations
everolimus
Source links and citations
gefitinib
Source links and citations
larotrectinib
Source links and citations
lazertinib
Source links and citations
lorlatinib
Source links and citations
necitumumab
Source links and citations
osimertinib
Source links and citations
pralsetinib
Source links and citations
ramucirumab
Source links and citations
repotrectinib
Source links and citations
selpercatinib
Source links and citations
sotorasib
Source links and citations
tepotinib
Source links and citations
trametinib
Source links and citations
Learn more about Targeted Therapy to Treat Cancer.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice